How I treat late effects in adults after allogeneic stem cell transplantation
Blood, ISSN: 0006-4971, Vol: 117, Issue: 11, Page: 3002-3009
2011
- 112Citations
- 141Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations112
- Citation Indexes112
- 112
- CrossRef67
- Captures141
- Readers141
- 141
- Mentions1
- News Mentions1
- News1
Most Recent News
Clinical updates in blood and marrow transplantation in multiple myeloma
[ILLUSTRATION OMITTED] The process of transplantation can be conceptualized through several phases (see Figure 1). Each phase carries with it distinct considerations and management strategies
Article Description
More than 25 000 allogeneic hematopoietic stem cell transplantations (allo-HCTs) are expected to be performed worldwide in 2010, a number that has been increasing yearly. With broadening indications, more options for allo-HCT, and improvement in survival, by 2020 there may be up to half a million long-term survivors after allo-HCT worldwide. These patients have increased risks for various late complications, which can cause morbidity and mortality. Most long-term survivors return to the care of their local hematologists/oncologists or primary care physicians, who may not be familiar with specialized monitoring recommendations for this patient population. The purpose of this article is to describe practical approaches to screening for and managing these late effects, with the goal of reducing preventable morbidity and mortality associated with allo-HCT.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0006497120411899; http://dx.doi.org/10.1182/blood-2010-10-263095; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=79953100650&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/21193694; https://facultyopinions.com/prime/13408976#eval14798055; http://dx.doi.org/10.3410/f.13408976.14798055; https://ashpublications.org/blood/article/117/11/3002/19547/How-I-treat-late-effects-in-adults-after; https://facultyopinions.com/prime/13408976#eval14779089; http://dx.doi.org/10.3410/f.13408976.14779089; https://dx.doi.org/10.1182/blood-2010-10-263095; http://www.bloodjournal.org/content/117/11/3002; http://www.bloodjournal.org/content/117/11/3002.abstract; http://www.bloodjournal.org/content/117/11/3002.full.pdf; https://ashpublications.org/blood/article-pdf/117/11/3002/1334658/zh801111003002.pdf; http://f1000.com/13408976#eval14779089; http://f1000.com/13408976#eval14798055; http://www.bloodjournal.org/cgi/doi/10.1182/blood-2010-10-263095
Faculty Opinions Ltd
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know